IONS Ionis Pharma: Net Sales Margin

ionispharma.com (IONS) - corporate logo

Ionis Pharmaceuticals management is transforming its strategy by shifting toward direct sales supported by investments in science. The company's net margin ratio demonstrates the effectiveness of this path, where the -56.90 level indicates the status of the parameter. Licensing technologies to industry behemoths creates powerful leverage by eliminating distribution costs, while financial stability relies on royalties and the success of clinical trials for new drugs.

ionispharma.com (IONS) - Net Margin from 07/04/2022 to 11/19/2026

Ionis Pharma - analytical breakdowns and key metrics (IONS)

- share price and expert price forecast:
Analysis of all company metrics:Ionis Pharmaceuticals, Inc. - IONS
Finished products of Ionis Pharmaceuticals, Inc.

Net profit margin measures the portion of profit remaining from revenue after deducting all operating and financial expenses, determining the efficiency of cost management. By analyzing the final sales margin, an investor assesses the ability of Ionis Pharmaceuticals (IONS) to capitalize on its own developments, which is evidenced by the transition from licensing to independently launching drugs to ensure full profit retention.

Main competitors

TEM: Net Sales Margin|Net Profitability Margin Qiagen QGEN|Net Margin Repligen|Avidity (RNA) - Company Sales Margin|Net Sales Margin CRSP|Company Sales Margin GeneDx|Net Margin Ultragenyx RARE|Company Sales Margin Beam Therapeutics (BEAM)|SRPT: Return on Sales by Net Profit|Net Margin Twist Bioscience|TXG (10x Genomics) - Return on Sales by Net Profit|Intellia Therapeutics, Inc. (NTLA) - Net Sales Margin|Net Margin Stoke Therapeutics Inc|BLFS: Net Profit Rate|Return on Sales by Net Profit WVE (Wave Life Sciences Corp)|Company Sales Margin Maze Therapeutics Corp|Sionna Therapeutics Inc - Return on Sales by Net Profit|PRME (primemedicine.com) - Net Profit Margin|TSHA - Net Margin|QURE (uniQure) - Net Return on Sales|MeiraGTx Corp (MGTX) - Net Margin|Regenxbio - Net Profit Rate|Net Margin solidbio.com|Net Margin ocugen.com OCGN|Net Sales Margin PACB|Benitec - Net Return on Sales|Net Margin Design Therapeutics DSGN|Net Sales Margin Rocket Pharmaceuticals RCKT|Net Profit Margin 4D Molecular Corp|LXEO: Net Margin|KRRO (Korro Bio, Inc) - Return on Sales by Net Profit|Editas Medicine (EDIT) - Net Sales Margin|Net Margin Silence Therapeutics Inc.|Net Return on Sales PRQR (proqr.com)|Net Margin Codexis Bio (CDXS)|Net Sales Margin sangamo.com (SGMO)|Net Margin nautilus.bio NAUT|Company Sales Margin Metagenomi, Inc (MGX)|Precision BioSciences Inc. - Net Sales Margin|GBIO - Net Sales Margin|BOLD: Net Sales Margin|Net Return on Sales XCUR|Net Margin Imunon|Phio Pharmaceuticals - Net Profit Margin|Net Margin Mustang Bio, Inc. (MBIO)|Company Sales Margin TransCode Therapeutics, Inc.|Net Margin Bionano Genomics BNGO|Net Profit Rate APDN|BLUE - Net Margin|Net Profit Margin IPA|Omega Therapeutics, Inc. (OMGA) - Net Margin|Singular Genomics Corp (OMIC) - Net Sales Margin|RGLS (Regulus Therapeutics, Inc.) - Net Sales Margin|SYRS: Net Profit Rate|Return on Sales by Net Profit TBIO (Telesis Bio Inc.)|Net Sales Margin TRACON Pharmaceuticals Inc. (TCON)|Net Margin Unity Bio UBX